NCT05262738View on ClinicalTrials.gov

Misoprostol Dosing in BMI Greater Than 30

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

July 14, 2023

Study Completion Date

July 17, 2023

Conditions
Pregnancy RelatedObesityLabor Onset and Length Abnormalities
Interventions
DRUG

50 Micrograms Vaginal Misoprostol (Intervention)

Subjects will undergo cervical ripening with 50 micrograms of vaginal misoprostol every 4 hours.

DRUG

25 Micrograms Vaginal Misoprostol (Control)

Subjects will undergo cervical ripening with 25 micrograms of vaginal misoprostol every 4 hours.

Trial Locations (1)

78705

University of Texas at Austin Dell Medical School, Department of Women's Health, Austin

All Listed Sponsors
lead

University of Texas at Austin

OTHER